BrainValue Neurotech

BrainValue Neurotech is developing the world's first emotional Brain Computer Interface (eBCI), with technology licensed from Weizmann Institute, to treat severe PTSD and other debilitating mental health conditions, a highly underserved market. Our implantable platform represents a paradigm shift in psychiatry, unlocking targeted neuronal-level neuromodulation treatment addressing the root cause and offering hope of restoring lives to millions of patients for whom existing therapies fall short.